Status | Study |
Active, not recruiting |
Study Name: APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis Condition: TTR-mediated Amyloidosis Amyloidosis, Hereditary Amyloid N Date: 2013-10-09 Interventions: Drug: patisiran (ALN-TTR02) ad |
Active, not recruiting |
Study Name: Tolerability and Efficacy of a Combination of Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy Condition: Amyloidosis; Heart (Manifestation) Senile Cardiac Amyloidosis Date: 2013-03-12 Interventions: Drug: Tauroursodeoxycholic Acid and Doxycycline |
Active, not recruiting |
Study Name: Efficacy and Safety of IONIS-TTR Rx in Familial Amyloid Polyneuropathy Condition: FAP Familial Amyloid Polyneuropathy Date: 2012-11-27 Interventions: Drug: IONIS-TTR Rx 300 mg IONI |
Active, not recruiting |
Study Name: Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy Condition: Cardiac Amyloidosis Amyloidosis in Transthyretin (TTR) Hyp Date: 2012-06-13 |
Completed |
Study Name: Burden of Disease Study In Patients With Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) orTransthyretin Cardiomyopathy (TTR-CM) And Caregivers Condition: Transthyretin Familial Amyloidosis Polyneuropathy (TTR-FAP) Transthyretin Cardiomyopathy (TT Date: 2012-05-21 Interventions: Other: No drug No drug. |
Completed |
Study Name: Safety and Efficacy Study of Doxycycline/UrsoDeoxyCholicAcid on Disease Progression in ATTR Amyloidosis Condition: Transthyretin Amyloidosis Cardiomyopathy Date: 2012-04-19 Interventions: Drug: Doxycycline 200 mg/day ( |
Completed |
Study Name: The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin Condition: Transthyretin Familial Amyloid Polyneuropathy Date: 2011-09-13 Interventions: Drug: tafamidis tafamidis meglumine 20 mg QD Other N |
Completed |
Study Name: The Effect of Diflunisal on Familial Transthyretin Amyloidosis Condition: Amyloidosis Date: 2011-09-09 Interventions: Drug: Diflunisal Film-coated tablet, 250 mg twice daily, orally for approximately 2 years |
Completed |
Study Name: Safety, Efficacy and Pharmacokinetics of Doxycycline Plus Tauroursodeoxycholic Acid in Transthyretin Amyloidosis Condition: Transthyretin Amyloidosis Date: 2010-07-27 Interventions: Drug: Doxycycline + Tauroursodeoxycholic acid doxycycline 100 mg twice a day for 12 months; tauroursodeo |
Active, not recruiting |
Study Name: Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis Condition: ATTR-PN Date: 2009-06-17 Interventions: Drug: Tafamidis 20 mg oral Fx-1006A daily |